Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board
Portfolio Pulse from
Dr. Jonathan Sadeh, former SVP of Immunology R&D at Bristol-Myers Squibb, has joined Scinai Immunotherapeutics' Scientific Advisory Board. Scinai, a biopharmaceutical company, focuses on inflammation and immunology products and CDMO services.
November 27, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Scinai Immunotherapeutics has appointed Dr. Jonathan Sadeh, a former senior executive at Bristol-Myers Squibb, to its Scientific Advisory Board. This move could enhance Scinai's expertise in immunology and inflammation products.
The appointment of Dr. Sadeh, with his extensive experience in immunology from Bristol-Myers Squibb, is likely to strengthen Scinai's R&D capabilities. This could lead to advancements in their product offerings, positively impacting SCNI's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90